1.Leonard, BE. Editorial: Litigation and the toxicity of psychotropic drugs. Ir J Psychol Med 1996; 13:88–9
2.Casey, P. Commentary: Litigation and the toxicity of psychotropic drugs. Ir J Psychol Med 1996; 13:89–90
3.Carlston, A, Allebeck, P, Brandt, L. Are suicide rates in Sweden associated with changes in the prescribing of medicines? Acta Psychiat Scand 1996; 94: 94–100.
4.Farmer, RDT. Suicide and poisons. Human Psychopharmac 1994; 9(1): S1–S21.
5.Henry, JA, Alexander, CA, Sener, EK. Relative mortality from overdose of antidepressives. BMJ 1995; 310: 221–4.
6.Daly, RJ. Medico-legal aspects of prescribing. Human Psychopharmac 1994; 9(1):S31–S36.
7.de Gier, JJ. Drugs other than alcohol and driving in the European Union. Study coordinated with the support of the European Blood Safety Federation and the Directorate General for Transport of the Commission for the European Communities. EC document 1995; IHP: 95–94.
8.Ray, WA, Fought, RL, Decker, MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 16: 873–83.
9.Montgomery, SA, Henry, JA, McDonald, G, et al.Selective serotonin re-uptake inhibitors: meta analysis of discontinuation rates. Int Clin Psychopharmac 1994; 9: 47–53.